Windjammer Capital Investors is pleased to announce that its portfolio company, Hilco Vision has acquired ophthalmic supplies company, Suppleyes, effective June 1, 2020. Based in Madison, Mississippi, Suppleyes has helped the professional eyecare market meet its inventory needs for over 30 years.
As part of the acquisition, Suppleyes will be integrated into Hilco’s ophthalmic supplies subsidiary, Eye Care and Cure. Together Hilco Vision and Eye Care and Cure offer a national distribution network for eye care professionals with over 30,000 products in stock covering everything from pharmaceuticals and diagnostics to vision care and optical products.
Ross Brownlee, CEO of Hilco Vision, noted, “Over several decades Suppleyes has developed a high value relationship with eye care professionals. As we worked through the process of coming together, we came to appreciate our shared commitment to putting service at the heart of all that we do. By integrating Suppleyes into our ophthalmic supplies subsidiary, Eye Care and Cure, we allow that focus and service culture to thrive, while providing Suppleyes customers an even broader portfolio of pharmaceutical, diagnostic and optical supplies, truly giving them a one-stop-shop. The COVID-19 pandemic has tested us all in so many ways but Hilco Vision remains committed to broadening our offering to the eye care professional via both acquisition and innovation.”
Shane Hixon, owner of Suppleyes commented, “We could not be happier to share our customers in the eye care industry with a company like Hilco Vision which has such a strong track record in customer service.”
Matt Anderson, Managing Director at Windjammer said, “We are excited to work with and support the management team at Hilco in their ongoing efforts to grow both organically and through acquisition. Suppleyes is a great fit for Hilco and supports our ongoing strategy to broaden the Company’s product portfolio to create value for its customers.”
ABOUT HILCO VISION
Hilco Vision, based in Plainville, Massachusetts, is an industry leading global eyewear/eye care company delivering comprehensive solutions to customers, built on a platform of innovation and operational excellence. It has direct subsidiaries, including Eye Care and Cure, in the USA, Canada, UK, Germany, Australia, China, and the Netherlands. The company’s product portfolio is concentrated on 5 primary product categories: Professional Tools, Vision Protection, Consumer Accessories, Lenscare and Ophthalmic Supplies.
ABOUT WINDJAMMER CAPITAL
Windjammer Capital is a national private equity investment firm, based in Newport Beach, CA and Waltham, MA that invests control equity in middle‐market businesses and in partnership with management. Since the firm’s founding in 1990, Windjammer has managed over $2 billion in committed capital with respect to its control equity investment strategy, and has completed over 50 platform investments and more than 100 strategic add‐ons. The firm targets investments in companies that are leaders in attractive niche markets and share several of the following characteristics: significant and defensible market positions; differentiated products and services; strong management teams; scalable business models; identifiable growth opportunities; and consistent financial performance. For more information please visit www.windjammercapital.com.
